Both Duox2 and DuoxA2 exhibit overexpression in human pancreatic and colorectal cancer cells, thereby increasing the susceptibility of these cells to tumor progression via the generation of elevated levels of reactive oxygen species (ROS) that promote tumor progression. This evidence concerns the gene DUOXA2 and neoplasm.